arrow
F

Francesco Claps

Veneto Institute of Oncology IRCCS
H指数:21
被引数:1,396

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surrogacy of intermediate clinical endpoints for overall survival in BCG-naïve high-risk non-muscle-invasive bladder cancer

BCG-naïve高危非肌层浸润性膀胱癌中总体生存率的中间临床终点替代性研究

2026-10-010
PRE
Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter Analysis

预测高危非肌层浸润性膀胱癌患者中BCG无应答疾病的发展:一项国际多中心分析

2026-09-010
OAAI
Real-World Outcomes of DNA Damage Repair Altered Metastatic Castration-Resistant Prostate Cancer: Insights from FFPE-Based Genomic Profiling

真实世界DNA损伤修复改变转移性去势抵抗性前列腺癌的结局:基于FFPE的基因组分析启示

Cancers
IF4.4
2026-07-260
OA
Comparative efficacy of perioperative systemic therapies for muscle-invasive bladder cancer: a network meta-analysis of randomized trials

肌层浸润性膀胱癌围手术期全身治疗比较疗效:随机试验的网络荟萃分析

2026-07-220
OAAI
Survival Outcomes of BCG Only, BCG Plus EMDA-MMC or Upfront Radical Cystectomy in High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): A Multicentre, International, Collaborative Study from Tertiary Referral Institutions
Cancers
IF4.4
2026-02-030
OAAI
Monoclonal Gammopathy Prevalence in Newly Diagnosed Prostate Cancer Patients: A Correlative Perspective Observational Study

新诊断前列腺癌患者中单克隆丙种球蛋白病的患病率:一项相关性视角的观察性研究

2025-11-270
OAAI
Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy

组织学分级是否是浸润性尿路上皮膀胱癌的有用参数?来自一项关于不同分级系统对根治性膀胱切除术术后无病生存期影响的多中心研究的结果

2025-11-200
OAAI
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancer

四层混合分级系统在Ta非肌层浸润性膀胱癌中增强的预后价值

2025-06-250
PRE
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guerin response among bladder cancer patients: a novel machine-learning approach
2024-12-012
PRE
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding
2024-07-030
OAAI
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
2024-05-016
OAAI
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program

对意大利泌尿科学员的偏好,态度和观点的调查: 新型国家住院医师匹配计划的含义

2023-12-014
PRE
Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility
2023-07-314
OAAI